1.Early Squamous Cell Carcinoma Arising from Disseminated Superficial Actinic Porokeratosis.
Eo Gin LEE ; Jae Yang PARK ; Sang Eun LEE ; Hee Jung LEE ; Moon Soo YOON
Korean Journal of Dermatology 2014;52(1):72-73
No abstract available.
Carcinoma, Squamous Cell*
;
Porokeratosis*
2.Cerebellopontine Angle Lipoma Representing Trigeminal Neuralgia: Case Report.
Choong Seon YOO ; Han Kyu KIM ; Yong Soon HWANG ; Jae Gin MOON ; Hwa Dong LEE ; Young Duk JOH
Journal of Korean Neurosurgical Society 1994;23(11):1344-1348
A case of rare symptomatic cerebellopontine angle lipoma treated by surgical decompression is described. In this 28-year-old male with intermittent facial pain 17 years, a mass was noted in the right cerebellopontine angle on C-T and MRI. Partial removal of the mass was made for decompression of the lesion from the trigeminal nerve root entry zone. The surgical biopsy results was lipoma. This represents, to our knowledge, the first lipoma in the cerebellopontine angle reportes in the Korean literature.
Adult
;
Biopsy
;
Cerebellopontine Angle*
;
Decompression
;
Decompression, Surgical
;
Facial Pain
;
Humans
;
Lipoma*
;
Magnetic Resonance Imaging
;
Male
;
Neuroma, Acoustic
;
Trigeminal Nerve
;
Trigeminal Neuralgia*
3.Prophylactic Effect of Lactobacillus GG in Animal Colitis and Its Effect on Cytokine Secretion and Mucin Gene Expressions.
Gyoo MOON ; Seung Jae MYUNG ; Jin Yong JEONG ; Suk Kyun YANG ; Yoon Kyung CHO ; Sun Mi LEE ; Hye Sook CHANG ; Jeong Sik BYEON ; Yun Jung LEE ; Gin Hyug LEE ; Weon Seon HONG ; Jin Ho KIM ; Young Il MIN ; Jung Sun KIM
The Korean Journal of Gastroenterology 2004;43(4):234-245
BACKGROUND/AIMS: Lactobacillus rhamnosus GG (LGG) has been used in acute colitis treatment. However, it is unclear whether the LGG prevents chronic colitis. The aim of this study was to examine the prophylactic effect of LGG on animal colitis, cytokine secretion, and mucin gene expression. METHODS: BALB/c mice (n=64) were exposed to 5% dextran sulfate sodium (DSS) for 7 days followed by 10 days recovery period and repeatedly exposed for 4 days. Then, the mice were devided into three group; group of oral LGG adminstration throughout the recovery and repeated colitis period; PBS group of PBS administration; control group. Colon length, histologic score, tumor necrosis factor-alpha (TNF-alpha), interleukin-10 (IL-10) levels, mucin gene expressions were determined at each period. RESULTS: In acute colitis period, the LGG group showed higher levels of disease activity index (DAI), histologic score, TNF-alpha, IL-10, but shorter colon length, lower levels of mucin gene expressions than the control group. However, in repeated colitis period, the LGG group showed markedly lower levels of DAI and IL-10 but significantly longer colon length than PBS group (p<0.05). There was no difference in the mucin gene expression. CONCLUSIONS: These results suggest that LGG prevents chronic murine colitis. It may be associated with cytokine modulation and competitive inhibition of pathogenic bacteria. However, it may not be related with gene expression.
Animals
;
Colitis/*prevention & control
;
Cytokines/*metabolism
;
English Abstract
;
Gene Expression/*drug effects
;
*Lactobacillus
;
Mice
;
Mice, Inbred BALB C
;
Mucins/*genetics/metabolism
;
Probiotics/*therapeutic use